Market Research Logo

Oncolytics Biotech Inc (ONC) - Financial and Strategic SWOT Analysis Review

Oncolytics Biotech Inc (ONC) - Financial and Strategic SWOT Analysis Review provides

- you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is indicated for the treatment of lung, ovarian, colorectal, pancreatic, prostate, breast, head and neck cancers. Reolysin is also undergoing various other clinical trials to determine its use in other types of cancer, such as for squamous cell carcinoma, metastatic colorectal cancer, metastatic melanoma trial, and non-small cell lung cancer. The company and its partners conduct clinical trials across Canada and the US. Oncolytics is headquartered in Calgary, Alberta, Canada.

Oncolytics Biotech Inc Key Recent Developments

May 29,2018: Oncolytics Biotech Announces New OTCQX Ticker Symbol
May 25,2018: Oncolytics Biotech® Announces Research Collaboration with the Keck School of Medicine of USC Combining REOLYSIN® with Keytruda®, Velcade® and Dexamethasone
May 11,2018: Oncolytics Biotech Reports 2018 First Quarter Results
Apr 17,2018: Oncolytics Biotech Announces Resignation Of Andres Gutierrez As Chief Medical Officer
Mar 09,2018: Oncolytics Biotech Announces 2017 Year End Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Oncolytics Biotech Inc - Key Facts
Oncolytics Biotech Inc - Key Employees
Oncolytics Biotech Inc - Key Employee Biographies
Oncolytics Biotech Inc - Major Products and Services
Oncolytics Biotech Inc - History
Oncolytics Biotech Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Oncolytics Biotech Inc - Business Description
Oncolytics Biotech Inc - Corporate Strategy
Oncolytics Biotech Inc - SWOT Analysis
SWOT Analysis - Overview
Oncolytics Biotech Inc - Strengths
Oncolytics Biotech Inc - Weaknesses
Oncolytics Biotech Inc - Opportunities
Oncolytics Biotech Inc - Threats
Oncolytics Biotech Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Oncolytics Biotech Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 29, 2018: Oncolytics Biotech Announces New OTCQX Ticker Symbol
May 25, 2018: Oncolytics Biotech® Announces Research Collaboration with the Keck School of Medicine of USC Combining REOLYSIN® with Keytruda®, Velcade® and Dexamethasone
May 11, 2018: Oncolytics Biotech Reports 2018 First Quarter Results
Mar 09, 2018: Oncolytics Biotech Announces 2017 Year End Results
Mar 08, 2018: Oncolytics Biotech Chief Medical Officer to Facilitate Roundtable Discussion at the US Immuno-Oncology Strategy Meeting
Jan 25, 2018: Oncolytics Biotech Named to the 2018 OTCQX Best 50
Jan 25, 2018: Oncolytics Biotech Named to the 2018 OTCQX Best 50
Nov 08, 2017: Oncolytics Biotech Announces 2017 Third Quarter Results
Aug 03, 2017: Oncolytics Biotech Announces 2017 Second Quarter Results
Jun 29, 2017: Oncolytics Biotech Appoints Andrew de Guttadauro, President of Oncolytics Biotech
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Oncolytics Biotech Inc, Key Facts
Oncolytics Biotech Inc, Key Employees
Oncolytics Biotech Inc, Key Employee Biographies
Oncolytics Biotech Inc, Major Products and Services
Oncolytics Biotech Inc, History
Oncolytics Biotech Inc, Other Locations
Oncolytics Biotech Inc, Subsidiaries
Oncolytics Biotech Inc, Key Competitors
Oncolytics Biotech Inc, Ratios based on current share price
Oncolytics Biotech Inc, Annual Ratios
Oncolytics Biotech Inc, Annual Ratios (Cont...1)
Oncolytics Biotech Inc, Interim Ratios
Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Oncolytics Biotech Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Oncolytics Biotech Inc, Performance Chart (2013 - 2017)
Oncolytics Biotech Inc, Ratio Charts
Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report